Mizuho on Arcus Biosciences (RCUS): stock's dip today 'doesn't make sense'
Tweet Send to a Friend
Mizuho analyst Salim Syed reiterated an Outperform rating and $47.00 price target on Arcus Biosciences (NYSE: RCUS)The analyst commented, "RCUS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
